SAGE
SAGE Therapeutics Inc
Price:  
11.70 
USD
Volume:  
936,475.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

SAGE WACC - Weighted Average Cost of Capital

The WACC of SAGE Therapeutics Inc (SAGE) is 6.8%.

The Cost of Equity of SAGE Therapeutics Inc (SAGE) is 9.85%.
The Cost of Debt of SAGE Therapeutics Inc (SAGE) is 5.00%.

Range Selected
Cost of equity 7.90% - 11.80% 9.85%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 5.00% - 5.00% 5.00%
WACC 5.8% - 7.7% 6.8%
WACC

SAGE WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.87 1.24
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.90% 11.80%
Tax rate 26.20% 27.00%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 5.8% 7.7%
Selected WACC 6.8%